Education
About Us
Working with TipRanks
Follow Us
Global Health Limited (IN:MEDANTA)
:MEDANTA
See the Price Targets and Ratings of:
MEDANTA Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
₹1,380→₹1,530
Buy
32.77%
Upside
Reiterated
08/12/25
HSBC
₹965→₹1,200
Sell
4.14%
Upside
Reiterated
08/11/25
J.P. Morgan
₹1,240→₹1,480
Hold
28.43%
Upside
Reiterated
08/11/25
Kotak Mahindra
₹1,275→₹1,460
Buy
26.70%
Upside
Reiterated
08/11/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
₹1,380→₹1,530
Buy
32.77%
Upside
Reiterated
08/12/25
HSBC
₹965→₹1,200
Sell
4.14%
Upside
Reiterated
08/11/25
J.P. Morgan
₹1,240→₹1,480
Hold
28.43%
Upside
Reiterated
08/11/25
Kotak Mahindra
₹1,275→₹1,460
Buy
26.70%
Upside
Reiterated
08/11/25
Best Analysts Covering Global Health Limited
1 Month
xxx
Success Rate
2/4 ratings generated profit
Average Return
-1.15%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.15% per trade.
3 Months
xxx
Success Rate
1/4 ratings generated profit
Average Return
+0.05%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +0.05% per trade.
1 Year
Success Rate
4/4 ratings generated profit
Average Return
+8.72%
reiterated a sell rating 4 months ago
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.72% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
Average Return
+8.72%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +8.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MEDANTA Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
5
6
5
4
2
Hold
1
2
1
1
1
Sell
2
3
2
1
0
Strong Sell
0
0
0
0
0
total
8
11
8
6
3
Each month's total comprises the sum of three months' worth of ratings.
MEDANTA Stock Forecast FAQ
What is IN:MEDANTA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:MEDANTA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:MEDANTA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Global Health Limited a Buy, Sell or Hold?
Global Health Limited has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Global Health Limited’s share price target?
Currently, no data Available
What do analysts say about Global Health Limited?
Global Health Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Global Health Limited?
To buy shares of IN:MEDANTA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.